Bethesda, Md. — AABB is pleased to announce it will be co-sponsoring a conference in January 2018 in the United Arab Emirates. The conference, “AABB Annual Meeting Highlights Conference and Exhibition in the Middle East 2018,” will be the first conference for AABB in the Middle East and will feature presentations from experts in the fields of transfusion medicine, cellular therapies and patient blood management.
Sponsored in collaboration with InfoPlus Events, LLC (IPE), “AABB Annual Meeting Highlights Conference and Exhibition in the Middle East 2018” will be held January 26-27, 2018, at the Abu Dhabi National Exhibition Centre in Abu Dhabi, United Arab Emirates.
“AABB is proud to be sponsoring its first conference in the Middle East region,” said Mary Beth Bassett, BS, MT(ASCP), president of AABB. “Through this event, AABB will be supporting and reinforcing its vision of making transfusion medicine and cellular therapies safe, effective and available worldwide.”
The conference is designed to bring the latest news, information and best practices on transfusion medicine, cellular therapies and patient blood management to professionals in the Middle East. Presentations will be led by experts in these fields. The conference will comprise various comprehensive informative sessions, panel discussions, workshops and industry symposia. The target audience for the conference includes CEOs, medical directors, laboratory supervisors, administrators (local health authorities), allied health professionals (technologist), pathologists, transfusion medicine physicians, cellular therapy and blood banking professionals, medical technologists, clinical physicians, nurses and fellows/trainees.
“AABB is pleased to have this opportunity to present best practices in transfusion medicine, cellular therapies and patient blood management outside of our Annual Meeting,” said Zbigniew M. Szczepiorkowski, MD, PhD, FCAP, immediate past president of AABB. “The location of this conference allows for ‘closer to home’ participation of transfusion medicine specialists and those interested in learning more from the Middle East, Africa and Asia. It will be an ideal opportunity for professionals in transfusion medicine, cellular therapies and patient blood management to advance their understanding of the latest information affecting the fields.”
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.